Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr
The Perfect Holiday Gift Gift Now

'Deadly Risk' of Fat-Loss Drugs

Newsweek Europe

|

March 22, 2024

Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts

- PANDORA DEWAN

'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

WEITERE GESCHICHTEN VON Newsweek Europe

Newsweek Europe

Newsweek Europe

WORLD'S MOST ANTICIPATED NEW VEHICLES 2026

Excitement is building for these autos, coming soon to global markets

time to read

2 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

From the Arctic to the Sahara, Extremes Put New Vehicles to the Test

BATTLE TESTED Mercedes-Benz GLB undergoes extreme conditions testing in Germany.

time to read

1 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

PAUL FEIG

DIRECTOR PAUL FEIG WANTS YOU TO SUPPORT LOCAL MOVIE THEATERS, ideally at his new movie The Housemaid, based on the popular book series by Freida McFadden.

time to read

1 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

General Motors Is Laser-Focused on F1 & Global Expansion

WHILE CHINESE CAR COMPANIES HAVE BEEN THE subject of most of the attention for their global expansion plans, one of America’s oldest automakers has similar ambitions.

time to read

3 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

RISKY BUSINESS

As President Donald Trump weighs action against Venezuela's leader Nicolás Maduro, experts warn that intervention could trigger a violent, yearslong insurgency

time to read

10 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

Behind Russia's Battle Lines

Exclusive images taken along the Russia-Ukraine frontier offer a first look inside Moscow's ranks

time to read

2 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

ERIKA ALEXANDER & KIM COLES

Erika Alexander and Kim Coles on their podcast ReLiving Single, the “limitless creativity” of Living Single and the sitcom’s enduring impact on pop culture

time to read

2 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

SPOILT FOR CHOICE

Car buyers have never had more brands and technology options to pick from than now

time to read

6 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

BROOKS RETURNS TO FORM

The legendary director of movies including Terms of Endearment finds humor and heartache in Ella McCay

time to read

6 mins

December 26, 2025

Newsweek Europe

Newsweek Europe

'IF HE GETS RID OF MADURO, WE'LL FORGIVE HIM'

Venezuelan exiles in a Miami suburb are backing Trump's efforts to remove the leader from power

time to read

4 mins

December 26, 2025

Listen

Translate

Share

-
+

Change font size

Holiday offer front
Holiday offer back